85
Views
3
CrossRef citations to date
0
Altmetric
Therapy

Vaccine progress

, , , &
Pages S394-S400 | Received 25 Sep 2008, Published online: 26 Feb 2009

References

  • Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–415
  • Pappas, PG. Prospective surveillance for invasive fungal infections in solid organ and stem cell transplant recipients. An overview of TRANSNET. Focus on Fungal Infections 17. San Diego, California, 7–9 March 2007.
  • Stevens DA. Vaccinate against aspergillosis! A call to arms of the immune system. Clin Infect Dis 2004; 38: 1131–1136
  • Cenci E, Mencacci A, Bacci A, et al. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 2000; 165: 381–388
  • Bozza S, Gaziano R, Lipford GB, et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect 2002; 4: 1281–1290
  • Bozza S, Perruccio K, Montagnoli C, et al. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 2003; 102: 3807–3814
  • Shao C, Qu J, He L, et al. Dendritic cells transduced with an adenovirus vector encoding interleukin-12 are a potent vaccine for invasive pulmonary aspergillosis. Genes Immun 2005; 6: 103–114
  • Torosantucci A, Bromuro C, Chiani P, et al. A novel glycol-conjugate vaccine against fungal pathogens. J Exp Med 2005; 202: 587–606
  • Capilla, J, Clemons, KV, Stevens, DA. The friend of man a friend again? Saccharomyces (S) as a vaccine against invasive aspergillosis. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 17–20 September 2007.
  • Ito JI, Lyons JM. Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis. J Infect Dis 2002; 186: 869–871
  • Ito JI, Lyons JM, Hong TB, et al. Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f3 protect mice against invasive aspergillosis. Infect Immun 2006; 74: 5075–5084
  • Hemmann S, Ismail C, Blaser K, et al. Skin test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus. Clin Exp Allergy 1998; 28: 860–867
  • Ramachandran H, Jayaraman V, Ban nerjee B, et al. IgE binding conformational epitopes of Asp f3, a major allergenc of Aspergillus fumigatus. Clin Immunol 2002; 103: 324–333
  • Diaz-Arevalo, D, , et al.T cell responses to proteolytic peptides of Aspergillus fumigatus proteins: identification of vaccine candidates to enhance cell-mediated protection from fungal infection. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 17–20 September 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.